Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Protein Expr Purif. 2012 Feb 20;82(2):389–395. doi: 10.1016/j.pep.2012.02.010

Table 1.

Formulation of mPRDC refolding solutions

Solution a 1 2 3 4 5 6 7 8 9 10
Tris HCl pH 8.5 (50 mM) --b --c
NaCl (150 mM) --d
GSH/GSSG (5 mM/5 mM) --e --f
Cysteine (0.5 mM) --g
EDTA (5 mM)
Arginine (0.5 M) --h --i --j
% Inhibitionk 98.5 39.6 0 0 98.2 93.4 92.8 97.3 87.3 98.4
Yield (μg/μl)l 0.05 <0.01 <0.01 <0.01 0.03 0.04 0.03 0.03 0.04 0.03
Precipitationm * *** *** ***** * * *** ** ** **
a

Components used for each solution unless otherwise noted:

b

Tris HCl, pH 7.4;

c

MES pH 5;

d

1 M NaCl;

e

5 mM/1 mM GSH/GSSG;

f

1 mM/5 mM GSH/GSSG;

g

0mM cysteine,

h

1% CHAPS;

i

1% sodiumtaurodeoxycholate;

j

No arginine.

k

Inhibitory activity of 10 μl of refolded, dialyzed protein on BMP2 signaling in the luciferase reporter assay.

l

Total protein recovery as measured by BCA.

m

Precipitation was scored using a five-point scale from one

*

indicating no precipitation to five

*****

indicating mostly precipitated.